Carolina, PR, site joins nine others in DHL’s global network
Continuing a program that began several years ago, DHL’s Global Forwarding division (US HQ: Plantation, FL) has opened its tenth facility with staff and equipment specific to life sciences logistics, including biopharmaceuticals, medical devices, APIs and biological materials. Additional temperature- and humidity-control equipment will be installed in the 70,000-sq.ft. facility this year, and staff has been trained and certified in the QEP program run by Envirotainer (Lagga Marma, Sweden), a major provider of active and passive temperature-control shipping containers. The facility is also rated for the Dept. of Homeland Security’s C-TPAT program (for anti-terrorist measures) and ISO 9001, according to Angelos Orfanos, president of the life sciences & healthcare unit in DHL Global Customer Solutions.
Despite DHL’s parent company’s withdrawal from U.S. small-package express operations at the end of last year, DHL Global Forwarding, Air Express and Exel supply chain operations continue to be active in the U.S. market, says Orfanos. Besides managing international air or ocean shipping through its own business unit, DHL will use appropriate ground carriers for domestic deliveries. And its LifeConex j.v. (with Luftansa’s air cargo unit) continues to provide value-added shipment-monitoring services to pharma manufacturers.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.